MoneyWorks4Me

Bliss GVS Pharma - Quaterly Results

29 Jul 2025 Evaluate
The June 2025 quarter revenue stood at Rs. 1633.64 millions, up 9.67% as compared to Rs. 1489.63 millions during the corresponding quarter last year.A humble growth in net profit of 8.41% reported in the quarter ended June 2025 to Rs. 210.54  millions from Rs. 194.21 millions.OP of the company witnessed a marginal growth to 433.61 millions from 335.83 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 1633.64 1489.63 9.67 1633.64 1489.63 9.67 6672.05 6054.60 10.20
Other Income 105.93 68.41 54.85 105.93 68.41 54.85 362.16 335.01 8.10
PBIDT 433.61 335.83 29.12 433.61 335.83 29.12 1278.02 1406.68 -9.15
Interest 51.12 11.68 337.67 51.12 11.68 337.67 65.84 58.06 13.40
PBDT 382.49 324.15 18.00 382.49 324.15 18.00 1212.18 937.76 29.26
Depreciation 76.85 62.61 22.74 76.85 62.61 22.74 270.47 235.19 15.00
PBT 305.64 261.54 16.86 305.64 261.54 16.86 941.71 702.57 34.04
TAX 95.10 67.33 41.24 95.10 67.33 41.24 252.03 196.13 28.50
Deferred Tax -30.39 -2.95 930.17 -30.39 -2.95 930.17 -47.89 -75.49 -36.56
PAT 210.54 194.21 8.41 210.54 194.21 8.41 689.68 506.44 36.18
Equity 105.50 104.88 0.59 105.50 104.88 0.59 105.37 104.69 0.65
PBIDTM(%) 26.54 22.54 17.73 26.54 22.54 17.73 19.15 23.23 -17.55
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..